| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,340 |
1,273 |
$434K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,867 |
3,273 |
$168K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,268 |
4,437 |
$166K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,116 |
2,703 |
$111K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,293 |
1,145 |
$90K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
222 |
209 |
$66K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
973 |
845 |
$59K |
| 86769 |
|
2,660 |
2,304 |
$56K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,117 |
1,595 |
$31K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,476 |
1,270 |
$23K |
| 95117 |
|
2,669 |
906 |
$21K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
253 |
233 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
990 |
460 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
836 |
790 |
$10K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
125 |
116 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
725 |
595 |
$5K |
| 86328 |
|
111 |
99 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
257 |
238 |
$3K |
| 86318 |
|
285 |
237 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
255 |
204 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
127 |
108 |
$2K |
| 81002 |
|
616 |
551 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
101 |
50 |
$1K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$732.42 |
| 92551 |
|
23 |
22 |
$209.88 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
12 |
$97.68 |
| 36415 |
Collection of venous blood by venipuncture |
34 |
25 |
$7.00 |
| 90686 |
|
333 |
307 |
$0.38 |
| 91307 |
|
32 |
30 |
$0.37 |
| 90734 |
|
153 |
145 |
$0.10 |
| 90649 |
|
227 |
214 |
$0.05 |
| 90620 |
|
65 |
61 |
$0.04 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
14 |
$0.00 |
| 90685 |
|
15 |
15 |
$0.00 |
| 90715 |
|
30 |
30 |
$0.00 |
| 99072 |
|
52 |
46 |
$0.00 |
| 82948 |
|
21 |
13 |
$0.00 |